We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.65B
AUM Growth
+$191M
Cap. Flow
-$10.8B
Cap. Flow %
-654.14%
Top 10 Hldgs %
14.57%
Holding
1,395
New
459
Increased
207
Reduced
257
Closed
382
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCHW
126
DELISTED
Roth CH Acquisition I Co. Warrant
ROCHW
$2.98M 0.18%
+300,000
New +$304K
KBLMW
127
DELISTED
KBL Merger Corp. IV Warrant
KBLMW
$2.98M 0.18%
271,727
TMCWW
128
TMC The Metals Company Warrants
TMCWW
$450K
$2.95M 0.18%
+289,000
New +$352K
ZGYHW
129
DELISTED
Yunhong International Warrant
ZGYHW
$2.94M 0.18%
+298,414
New +$65.6K
SYNH
130
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.94M 0.18%
55,347
+35,108
+173% +$2.09M
IPOC.U
131
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
$2.9M 0.18%
210,587
-125,730
-37% -$1.52M
KRE icon
132
State Street SPDR S&P Regional Banking ETF
KRE
$4.69B
$2.9M 0.18%
+81,133
New +$3.06M
BIG
133
DELISTED
Big Lots, Inc.
BIG
$2.88M 0.17%
64,673
+34,773
+116% +$1.56M
LFLYW
134
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$2.85M 0.17%
288,373
CRWD icon
135
CrowdStrike
CRWD
$206B
$2.83M 0.17%
82,444
-25,404
-24% -$740K
OBIO icon
136
Orchestra BioMed
OBIO
$247M
$2.83M 0.17%
+257,253
New +$2.89M
ASND icon
137
CALL
Ascendis Pharma A/S
ASND
$16B
$2.81M 0.17%
182
RCL icon
138
Royal Caribbean
RCL
$86.7B
$2.79M 0.17%
43,160
+27,304
+172% +$1.61M
SPLK
139
DELISTED
Splunk Inc
SPLK
$2.76M 0.17%
14,677
+7,911
+117% +$1.58M
CLDX icon
140
Celldex Therapeutics
CLDX
$2.96B
$2.76M 0.17%
186,117
-22,719
-11% -$266K
CYTK icon
141
CALL
Cytokinetics
CYTK
$10.4B
$2.75M 0.17%
+1,271
New +$29.7K
FIS icon
142
Fidelity National Information Services
FIS
$23.1B
$2.72M 0.16%
18,482
-24,483
-57% -$3.54M
JETS icon
143
US Global Jets ETF
JETS
$804M
$2.71M 0.16%
+160,325
New +$2.72M
MGP
144
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$2.7M 0.16%
+96,461
New +$2.68M
PYPL icon
145
PayPal
PYPL
$49.5B
$2.69M 0.16%
13,666
-17,703
-56% -$3.33M
MDT icon
146
Medtronic
MDT
$111B
$2.69M 0.16%
25,908
+7,067
+38% +$710K
ZYME icon
147
CALL
Zymeworks
ZYME
$1.6B
$2.67M 0.16%
574
-308
-35% -$10.6K
J icon
148
Jacobs Solutions
J
$16.4B
$2.65M 0.16%
+34,470
New +$2.52M
CSGP icon
149
CoStar Group
CSGP
$12.2B
$2.64M 0.16%
31,110
-10,110
-25% -$806K
AVTX icon
150
Avalo Therapeutics
AVTX
$955M
$2.64M 0.16%
402
-11
-3% -$82.7K

Similar funds

Boothbay Fund Management's Q3 2020 Portfolio in Review

As of Q3 2020, Boothbay Fund Management held 1,395 positions worth $1.65B, up 13% from $1.46B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $10.8B in Q3 2020, closing 382 positions and reducing 257 holdings. Its most notable exit was Tesla, an estimated $10.7B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boothbay Fund Management opened a new position in Whiting Petroleum Corporation worth $6.63M.

  • Boothbay Fund Management's largest Q3 2020 buy was Whiting Petroleum Corporation: 383,266 shares worth $6.63M.
  • Boothbay Fund Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $28.6M increase.
  • Boothbay Fund Management's biggest Q3 2020 reduction was KBR, cutting an estimated $45.7M.
  • Boothbay Fund Management fully exited Tesla in Q3 2020, selling an estimated $10.7B.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $1.65B portfolio in Q3 2020.
  • Boothbay Fund Management opened 459 new positions and closed 382 in Q3 2020.
  • Boothbay Fund Management's portfolio value rose 13% quarter-over-quarter to $1.65B.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.